Matches in Wikidata for { <http://www.wikidata.org/entity/Q59135458> ?p ?o ?g. }
- Q59135458 description "article scientifique publié en 2018" @default.
- Q59135458 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q59135458 description "bài báo khoa học" @default.
- Q59135458 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59135458 description "scientific article published on 26 October 2018" @default.
- Q59135458 description "wetenschappelijk artikel" @default.
- Q59135458 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q59135458 name "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 name "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 name "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 type Item @default.
- Q59135458 label "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 label "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 label "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 altLabel "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 altLabel "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 altLabel "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 prefLabel "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 prefLabel "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 prefLabel "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 P1433 Q59135458-D05956B2-D0EA-4172-ADB4-82B80BA4E5AE @default.
- Q59135458 P1476 Q59135458-3E8CCF4D-0B96-469B-B1F4-32F10A75F832 @default.
- Q59135458 P2093 Q59135458-16A09849-94F5-46EB-ACE3-F432782410A0 @default.
- Q59135458 P2093 Q59135458-38AFCEAA-FAD8-4478-B1C2-8EFB702AB08C @default.
- Q59135458 P2093 Q59135458-77987AF0-0ADA-4FF1-B701-F4A9E152D0CE @default.
- Q59135458 P2093 Q59135458-872839F9-BA7E-423D-A0F0-3DB0AF135538 @default.
- Q59135458 P2093 Q59135458-ACD71D74-B01A-491E-8374-D0442256DCE4 @default.
- Q59135458 P2093 Q59135458-EE86384F-85F3-42A2-B2EA-D4535DC78EDA @default.
- Q59135458 P2093 Q59135458-F6254D7F-E8D0-4184-9378-82D600D32AFF @default.
- Q59135458 P275 Q59135458-1e5dbdde-b5bb-4702-b142-5488e292c1f5 @default.
- Q59135458 P2860 Q59135458-0375E0FF-5477-4DA9-821F-AEF582CA18A7 @default.
- Q59135458 P2860 Q59135458-0566B788-550E-40C0-BCBB-264EAAA79006 @default.
- Q59135458 P2860 Q59135458-0A2458CF-0467-4356-9882-BBD197F0F386 @default.
- Q59135458 P2860 Q59135458-1923C232-65F3-420E-A8B8-B633022DF258 @default.
- Q59135458 P2860 Q59135458-2262DB43-7B8F-43EA-969B-BEBFEB3AE29A @default.
- Q59135458 P2860 Q59135458-23C1BC15-433B-439F-80E7-20C94D15D0FA @default.
- Q59135458 P2860 Q59135458-2798FBCE-EA84-4A9B-88FB-63E3DEB13C37 @default.
- Q59135458 P2860 Q59135458-2A6C2012-A0F1-48C1-B787-0038C4472D2E @default.
- Q59135458 P2860 Q59135458-2B6B946E-ED1F-495B-9260-ED18E6BB6760 @default.
- Q59135458 P2860 Q59135458-2BAFAF96-A8D0-4832-90F9-503BB4B4FE72 @default.
- Q59135458 P2860 Q59135458-307A7F2E-8B97-4B6F-927B-16B1D10CDD8C @default.
- Q59135458 P2860 Q59135458-30EB18F6-1F5C-4D7A-8C40-E375D0EEFA0B @default.
- Q59135458 P2860 Q59135458-3E722732-091E-4650-9CAD-C6BDC9505B19 @default.
- Q59135458 P2860 Q59135458-5D7F94B1-B900-4031-AAB8-5B778DE7BB70 @default.
- Q59135458 P2860 Q59135458-6264F241-9184-4F10-8D67-4AAFAE2741EA @default.
- Q59135458 P2860 Q59135458-68EBA08F-2C44-4B76-99F9-F2BDAA61D1DC @default.
- Q59135458 P2860 Q59135458-7794E9E5-FBB9-47C6-AB2A-136E5F7C51A9 @default.
- Q59135458 P2860 Q59135458-88E4866A-B181-4A9F-A13D-E51DBB26FEC1 @default.
- Q59135458 P2860 Q59135458-89515E7C-8351-4A2B-BA3C-7B86F466D824 @default.
- Q59135458 P2860 Q59135458-9295705C-28DF-4E25-984B-D3F5E84846EA @default.
- Q59135458 P2860 Q59135458-9D975177-6EDE-4BAF-93E0-4C2FAE3CB2D2 @default.
- Q59135458 P2860 Q59135458-AD4894FB-3DCD-4C1F-A8A0-BFD1A805D0CF @default.
- Q59135458 P2860 Q59135458-B87CCDFD-4D46-4421-A9B2-86458C22E94A @default.
- Q59135458 P2860 Q59135458-BEDABD9B-6446-457E-9DE5-65E571C38AA3 @default.
- Q59135458 P2860 Q59135458-C8555564-9E03-4F22-84D3-E236AF228E63 @default.
- Q59135458 P2860 Q59135458-E3323D61-E6D9-4B28-B587-DB7825682BE9 @default.
- Q59135458 P2860 Q59135458-EA41646C-0741-45D8-8DBD-864AD198BB0B @default.
- Q59135458 P2860 Q59135458-F0401B2E-3356-4C0A-91E6-3F62D2EC476B @default.
- Q59135458 P2860 Q59135458-F7049CA3-70B2-42E9-A798-2B071FCF1185 @default.
- Q59135458 P2860 Q59135458-FCBC6C52-F157-40EE-A226-C6DCA1DBA767 @default.
- Q59135458 P304 Q59135458-6FBA99BC-B526-42A0-B96E-3DC73B18E50D @default.
- Q59135458 P31 Q59135458-072AD5F3-2738-4441-848F-CE9724FA94A8 @default.
- Q59135458 P356 Q59135458-7D2F2DB1-A5A6-4A67-8514-D4521038509D @default.
- Q59135458 P407 Q59135458-915E9AC3-8632-4480-9F8E-BD8432A6699D @default.
- Q59135458 P478 Q59135458-ADED2DF4-BA7B-4B9B-9804-20AFA9B37E4E @default.
- Q59135458 P50 Q59135458-290AFE68-19AA-407F-8B4F-3EC8CDF9A51F @default.
- Q59135458 P50 Q59135458-CE1A2F8B-48A1-4061-B4CA-0230E4623882 @default.
- Q59135458 P577 Q59135458-93344171-369E-43E7-BF2B-94A1EC73CE9C @default.
- Q59135458 P6216 Q59135458-948a14af-ecbc-46f5-99f2-16c42ac494ed @default.
- Q59135458 P698 Q59135458-C7947195-15BC-47C6-8C7B-45FA157EE6FC @default.
- Q59135458 P921 Q59135458-B40C4F0F-89C4-4533-86AD-D27AF1E05732 @default.
- Q59135458 P921 Q59135458-D681BE6B-7442-4654-B191-F91D8BC9A8D1 @default.
- Q59135458 P932 Q59135458-E73F08C7-3978-4E79-BD40-1EF0820E355F @default.
- Q59135458 P356 IDR.S169432 @default.
- Q59135458 P698 30464544 @default.
- Q59135458 P1433 Q15716352 @default.
- Q59135458 P1476 "Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections: cefoperazone-sulbactam associated with resistance and tigecycline increased the mortality" @default.
- Q59135458 P2093 "Chen Huang" @default.
- Q59135458 P2093 "Lihua Guo" @default.
- Q59135458 P2093 "Tianshui Niu" @default.
- Q59135458 P2093 "TingTing Xiao" @default.
- Q59135458 P2093 "Wei Yu" @default.
- Q59135458 P2093 "Xiao Yu" @default.
- Q59135458 P2093 "Yunbo Chen" @default.
- Q59135458 P275 Q18810331 @default.
- Q59135458 P2860 Q26991886 @default.
- Q59135458 P2860 Q29616084 @default.
- Q59135458 P2860 Q29616607 @default.
- Q59135458 P2860 Q33237577 @default.
- Q59135458 P2860 Q33549724 @default.
- Q59135458 P2860 Q34088730 @default.
- Q59135458 P2860 Q35567016 @default.
- Q59135458 P2860 Q36115632 @default.
- Q59135458 P2860 Q36218318 @default.
- Q59135458 P2860 Q36406755 @default.
- Q59135458 P2860 Q37150308 @default.
- Q59135458 P2860 Q37188148 @default.
- Q59135458 P2860 Q37330689 @default.
- Q59135458 P2860 Q37504215 @default.
- Q59135458 P2860 Q37760952 @default.